A An Accelerated Pathway for Targeted Cancer Therapies Joshua S. Benner, David Epstein, Stephen Friend, Cindy Geoghegan, David Kessler, Mark B. McClellan, Richard Schilsky, David Sidransky, and Ray Woosley Thursday, February 3, 2011
Developing the Sentinel System – A National Resource for Evidence Development Joshua S. Benner, Rachel E. Behrman, Jeffrey S. Brown, Mark B. McClellan, Richard Platt, and Janet Woodcock Wednesday, January 12, 2011
A An Evaluation of Recent Federal Spending on Comparative Effectiveness Research Joshua S. Benner, Erin K. Karnes, S. Lawrence Kocot, Mark B. McClellan, and Marisa R. Morrison Tuesday, October 5, 2010
T The New Sentinel Network — Improving the Evidence of Medical-Product Safety Joshua S. Benner, K. Arnold Chan, Janet Marchibroda, Mark B. McClellan, Richard Platt, and Marcus Wilson Monday, July 27, 2009
C Comparative Effectiveness Research: Priorities, Methods and Impact Joshua S. Benner, Alan M. Garber, Mark B. McClellan, David O. Meltzer, Steven Pearson, and Sean R. Tunis Tuesday, June 9, 2009
F Four Important Steps Toward 21st Century Care for Patients with Cancer Joshua S. Benner and Mark B. McClellan Monday, April 13, 2009
M Medicare Part D: Good for Patients and an Opportunity for Pharmacists Joshua S. Benner and S. Lawrence Kocot Monday, February 2, 2009
